文献速递心外重症与机械循环支持

儿童植入左心室辅助装置后的右心衰竭:Pedimacs注册数据分析

Right heart failure with left ventricular assist device implantation in children: An analysis of the Pedimacs registry database.
PubMed 文献 · J Heart Lung Transplant · 2019-11-28

该研究基于Pedimacs注册数据库,分析18岁以下儿童植入耐久性左心室辅助装置(LVAD)后右心衰竭(RHF)的发生率及预后。共纳入272例,RHF定义为需右心室辅助装置(RVAD)或延长正性肌力药物使用1周至1个月及1至3个月。结果显示仅LVAD患者中RHF常见(1周至1个月55%,1至3个月25%),且RHF与装置上死亡风险增加相关。

要点

  • 儿童耐久性LVAD植入后RHF常见,但后续需RVAD者较少。
  • RHF与装置上死亡风险增加独立相关。
  • 低龄、低体重、Intermacs 1级、化学性瘫痪及搏动性流VAD与RHF相关。

核心结论

  • 儿童耐久性LVAD植入后RHF常见,以延长正性肌力药物使用为指征的RHF与装置上死亡风险增加相关。

研究设计与样本

  • 回顾性分析Pedimacs注册数据库(2012年9月19日至2017年2月28日)中18岁以下植入耐久性LVAD的患者,排除单心室形态和临时装置,共272例。

主要发现

  • 272例中24个月随访期间37例死于装置上,主要死因为多器官衰竭和神经功能障碍。
  • 12例儿童发生RVAD,中位时间8.5天,其中9例心脏移植,3例死于装置上。
  • 仅LVAD患者中,1周至1个月RHF发生率为111/207(55%),1至3个月为28/116(25%)。
  • RHF与装置上死亡风险增加相关:>1个月风险比3.2(95%CI 1.4-7.7,p=0.007),>3个月风险比6.9(95%CI 2-23.1,p=0.002)。

关键数值与推荐

  • RHF定义为需要RVAD或延长正性肌力药物使用1周至1个月及1至3个月。
  • 与RHF相关的因素包括:较低年龄、较小体重、Intermacs 1级、化学性瘫痪和搏动性流VAD。

临床怎么用

  • 儿童LVAD植入后应密切监测RHF,尤其对于低龄、低体重、Intermacs 1级、化学性瘫痪及使用搏动性流VAD的高危患者。
  • 发生RHF可能提示装置上死亡风险增加,需加强管理并考虑早期干预。

局限性

  • 早期RVAD支持和更高等待list状态能否改善结局尚不清楚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of ventricular assist device (VAD) in children has increased, but the decision of left VAD (LVAD) vs biventricular support remains a challenge. Children who undergo LVAD placement are at risk for right ventricular failure (RHF), but the incidence has not been described. METHODS: Analysis was performed for patients <18 years old who underwent durable LVAD placement within the Pedimacs registry (September 19, 2012-February 28, 2017), excluding single ventricle morphology and temporary devices. RHF was defined as the need for right ventriculalr assist device (RVAD) or prolonged inotrope use between 1 week to 1 month and 1 to 3 months. End-points included death, heart transplant (HT), and recovery. RESULTS: A total of 272 durable LVAD were placed of which 37 died on device over 24 month follow-up, primarily from multiorgan failure and neurologic dysfunction. RVAD occurred in 12 children at median 8.5 days, with 9 undergoing HT and 3 dying on device. In patients with only LVAD, RHF was present in 111/207 (55%) between 1 week to 1 month and 28/116 (25%) between 1 and 3 months. Younger age, smaller weight, Intermacs profile 1, chemical paralysis, and pulsatile flow VAD were associated with RHF. RHF was associated with increased risk of death on device at both >1 month (hazard ratio 3.2, 95% CI 1.4-7.7, p = 0.007) and >3 month (hazard ratio 6.9, 95% CI 2-23.1, p = 0.002). CONCLUSIONS: In children, RHF is common after durable LVAD implantation, but subsequent RVAD is relatively rare. RHF in children, as indicated by prolonged inotrope support, was associated with an increased risk of death on the device. Whether early RVAD support and higher waitlist status may improve the outcome remains unknown.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Simpson KE, Kirklin JK, Cantor RS, et al. Right heart failure with left ventricular assist device implantation in children: An analysis of the Pedimacs registry database. J Heart Lung Transplant. 2019. PMID: 31926747. doi:10.1016/j.healun.2019.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。